Dynein: A Multifaceted Therapeutic Target and Its Dysregulation in Aberrant Cell Proliferation.
1/5 보강
This review examines the diverse functions of dyneins, a family of motor proteins involved in intracellular transport processes, the maintenance of cell polarity, and critical signaling pathways essen
APA
Garg J, Alisaraie L (2026). Dynein: A Multifaceted Therapeutic Target and Its Dysregulation in Aberrant Cell Proliferation.. Cytoskeleton (Hoboken, N.J.), 83(3), 93-122. https://doi.org/10.1002/cm.22041
MLA
Garg J, et al.. "Dynein: A Multifaceted Therapeutic Target and Its Dysregulation in Aberrant Cell Proliferation.." Cytoskeleton (Hoboken, N.J.), vol. 83, no. 3, 2026, pp. 93-122.
PMID
40417797 ↗
DOI
10.1002/cm.22041
Abstract 한글 요약
This review examines the diverse functions of dyneins, a family of motor proteins involved in intracellular transport processes, the maintenance of cell polarity, and critical signaling pathways essential for cell cycle progression. Dyneins' significant impact on critical cellular functions is mediated through their interactions with an array of organelles, including centrosomes, chromosomes, and endosomes. Dyneins also influence autophagy and immune evasion within the complex environment of cancer. This review underscores the significance of dyneins as an avenue of exploration for comprehending the intricate mechanisms that underpin cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.